CYCLACEL PHARMACEUTICALS INC - COM (CYCC)

CUSIP: 23254L603

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / COM
Total 13F shares
2,237,518
Share change
-220,480
Total reported value
$1,275,183
Put/Call ratio
0%
Price per share
$0.57
Number of holders
23
Value change
-$131,091
Number of buys
3
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 23254L603?
CUSIP 23254L603 identifies CYCC - CYCLACEL PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CYCLACEL PHARMACEUTICALS INC - COM (CYCC) as of Q1 2023

As of 31 Mar 2023, CYCLACEL PHARMACEUTICALS INC - COM (CYCC) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,237,518 shares. The largest 10 holders included Schonfeld Strategic Advisors LLC, ACADIAN ASSET MANAGEMENT LLC, SPHERA FUNDS MANAGEMENT LTD., Point72 Asset Management, L.P., RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, and McIlrath & Eck, LLC. This page lists 23 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.